A multicenter H-MRS study of the medial temporal lobe in AD and MCI

Neurology

Volumn 72, Issue 20, 2009, Pages 1735-1740

  Jessen, F ^a,b   Gur O ^b   Block, W ^b   Ende, G ^c   Frolich L ^c   Hammen, T ^d   Wiltfang, J ^e,f   Kucinski, T ^g   Jahn, H ^h   Heun, R ^a,i   Maier, W ^a   Kolsch H ^a   Komhuber, J ^e   Traber F ^b  

^a Psychiatry   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^d Department of Clinics of Neurology   (Germany)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^f UNIVERSITY OF DUISBURG ESSEN   (Germany)

^g KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^h UNIVERSITY OF HAMBURG   (Germany)

ⁱ UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE; CREATINE PHOSPHATE; N ACETYLASPARTIC ACID; ASPARTIC ACID; BIOLOGICAL MARKER; DIAGNOSTIC AGENT; DRUG DERIVATIVE; N-ACETYLASPARTATE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEASIBILITY STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MULTICENTER STUDY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TEMPORAL LOBE; COGNITIVE DEFECT; HISTOLOGY; METABOLISM; METHODOLOGY; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY;

AGED; ALZHEIMER DISEASE; ASPARTIC ACID; BIOLOGICAL MARKERS; COGNITION DISORDERS; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; TEMPORAL LOBE;

EID: 66149148314     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181a60a20     Document Type: Article

References (25)

1. Cummings JL, Doody R, Clark C. Disease-modifying therapies for Alzheimer disease: challenges to early intervention. Neurology 2007;69:1622-1634.
2. Kantarci K. 1H magnetic resonance spectroscopy in dementia. Br J Radiol 2007;80:Sl46-S152.
3. Moffett JR, Ross B, Arun P, Madhavarao CN, Nam-boodiri AM. N-acetylaspartate in the CNS: from neuro-diagnostics to neurobìology. Prog Neurobiol 2007;81: 89-131.
4. Schuff N, Capizzano AA, Du AT, et al. Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD. Neurology 2002;58:928-935.
5. Jessen F, Traeber F, Freymann N, et al. A comparative study of the different N-acetylaspartate measures of the medial temporal lobe in Alzheimer's disease. Dement Geri-atr Cogn Disord 2005;20:178-183.
6. Jessen F, Block W, Träber F, et al. Decrease of N-acetylaspartate in the MTL correlates with cognitive decline of AD patients. Neurology 2001;57:930-932.
7. Kantarci K, Weigand SD, Petersen RC, et al. Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 2007;28:1330-1339.
8. Chantal S, Braun CM, Bouchard RW, Labelle M, Bou-langer Y. Similar 1H magnetic resonance spectroscopic metabolic pattern in the medial temporal lobes of patients with mild cognitive impairment and Alzheimer disease. Brain Res 2004; 1003:26-35.
9. Modrego PJ, Fayed N, Pina MA. Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy. Am J Psychiatry 2005;162:667-675.
10. Godbolt AK, Waldman AD, MacManus DG, et al. MRS shows abnormalities before symptoms in familial Alzheimer disease. Neurology 2006;66:718-722.
11. Krishnan KR, Charles HC, Doraiswamy PM, et al. Randomized, placebo-controlled trial of the effects of donepe-zil on neuronal markers and hippocampal volumes in Alzheimer's disease. Am J Psychiatry 2003; 160:2003-2011.
12. Jessen F, Traeber F, Freymann K, Maier W, Schild HH, Block W. Treatment monitoring and response prediction with proton MR spectroscopy in AD. Neurology 2006;67: 528-530.
13. Modrego PJ, Pina MA, Fayed N, Díaz M. Changes in metabolite ratios after treatment with rivastigmine in Alzheimer's disease: a nonrandomised controlled trial with magnetic resonance spectroscopy. CNS Drugs 2006;20: 867-877.
14. Träber F, Block W, Freymann N, et al. A multicenter re-producibility study of single-voxel 1H-MRS of the medial temporal lobe. Eur Radiol 2006;16:1096-1103.
15. Jorm AF, Christensen H, Korten AE, Henderson AS, Ja-comb PA, Mackinnon A. Do cognitive complaints either predict future cognitive decline or reflect past cognitive decline? A longitudinal study of an elderly community sample. Psychol Med 1997;27:91-98.
16. Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment: beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256:240-246.
17. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
18. Naressi A, Couturier C, Devos JM, et al. Java-based graphical user interface for the MRUI quantitation package. MAGMA 2001;12:141-152.
19. van den Boogaart A, van Hecke P, van Huffel S, Graveron-Demilly D, van Ormondt D, de Beer R. MRUI: a graphical user interface for accurate routine MRS data analysis. Presented at 13th annual meeting of the European Society for Magnetic Resonance in Medicine and Biology (ESMRMB); 1996; Prague. Abstract.
20. Vanhamme L, van den Boogaart A, van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997;129:35-43.
21. Cavassila S, Deval S, Huegen C, van Ormondt D, Graveron-Demilly D. Cramér-Rao bounds: an evaluation tool for quantitation. NMR Biomed 2001;14:278-283.
22. Chao LL, Schuff N, Kramer JH, et al. Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients. Neurology 2005;64:282-289.
23. Dixon RM, Bradley KM, Budge MM, Styles P, Smith AD. Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease. Brain 2002; 125:2332-2341.
24. Schuff N, Capizzano AA, Du AT, et al. Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD. Neurology 2003;61:358-364.
25. Kantarci K, Petersen RC, Boeve BF, et al. 1H MR spectroscopy in common dementias. Neurology 2004;63: 1393-1398.